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The purpose of this clinical advisory is to provide options for HIV screening of incapacitated source 
patients in occupational settings in the Commonwealth. Occupational exposures are described and 
regulated by the Centers for Disease Control and Prevention (CDC), United States Public Health Service 
(USPHS), and the Occupational Safety and Health Administration (OSHA), whose documents and 
guidelines are referenced throughout this document. 
Background 
In a clinical setting, occupational exposure to blood and other bodily fluids can occur through contact with 
skin and mucous membranes, as well as through sharps injuries such as needlesticks. The OSHA 
Bloodborne Pathogens Standard requires that an exposed employee be provided with evaluation and 
follow-up “according to the recommendations of the U.S. Public Health Service current at the time these 
evaluations and procedures take place.”
1
 The CDC has developed recommendations to reduce the risk of 
becoming infected with HIV following an exposure.
2
 The CDC recommendations include determining the 
HIV status of the source patient, and determining possible administration of post-exposure prophylaxis 
(PEP). PEP is the short-term use of antiretroviral drugs after a single high-risk event to reduce the 
likelihood of HIV infection.
3
 
 
Among Health Care Workers (HCW), 58 confirmed and 150 possible cases of occupationally acquired 
HIV infection were reported to the CDC from 1985–2013.
4
 Since 1999, only one confirmed case of 
occupationally acquired HIV infection has been reported (in 2008, a laboratory technician sustained a 
needle puncture while working with a live HIV culture).
5
  Case reporting of HCW exposures is voluntary, 
therefore underreporting of cases to the CDC is possible. The risk of occupational transmission of HIV 
varies with the type and severity of exposure.
6,7,8 
The average risk for HIV transmission after a 
percutaneous exposure to HIV-infected blood has been estimated to be approximately 0.3% from 
prospective studies of health care workers (approximately 0.09% after a mucous membrane exposure).
9
   
US Public Health Service Guidelines 
The USPHS first issued recommendations for the use of PEP after occupational exposure to HIV in 
1996.
10
 The recommendations have been updated three times to reflect advances in testing technologies 
and anti-viral treatment options.6
,
7
,11
 The recommendations have continuously included determination of 
the HIV status of the exposure source patient to guide the need for HIV PEP.
12
 
 
The HIV status of the source patient should be determined as soon as feasible to guide appropriate use 
of HIV PEP. USPHS recommendations indicate that all current FDA-approved HIV tests can be used to 
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determine the HIV status of the source patient including rapid tests, third-generation immunoassays, and 
fourth-generation combination p24 antigen–HIV antibody (Ag/Ab) tests (which produce both rapid and 
accurate results, and their p24 antigen detection allows identification of most acute infections).
13
  MDPH 
recommends utilization of the fourth-generation combination p24 antigen-HIV antibody test to 
determine those source patients with acute infection. Determination of PEP initiation and utilization 
anti-retroviral treatments is described in the USPHS recommendations.
14
 
HIV Screening of Source Patients in Massachusetts 
Following an exposure, a source patient is asked to voluntarily disclose their HIV status, or voluntarily 
give consent to be tested for HIV. M.G.L. c. 111, §70F permits a patient to provide verbal informed 
consent to be tested for HIV (written informed consent may be substituted for verbal).
15
  However, 
disclosing the results of a person’s HIV test, or identifying a person as the subject of an HIV test, requires 
written informed consent. Thus, following an occupational exposure, the source patient would need to 
provide either written or verbal informed consent to be tested, and additionally provide written informed 
consent to release the test results to the exposed individual. Specific consent to release this test result 
may also be included in a general consent to care, or a general consent for release of medical 
information, so long as the consent for release of HIV test results is a discrete section of the general 
consent form.
16
 
HIV Screening of Incapacitated Source Patients in Massachusetts 
In certain instances, the source patient of an occupational exposure may be, or may become, 
incapacitated (unable to make or communicate health care decisions) and incapable of providing verbal 
consent to testing or written consent for the release of test results.
17
 When a health care worker is 
exposed to the blood or other potentially infectious materials of a patient who is incapacitated, clinical 
staff should consult with legal counsel. In these cases, there are two options to determine the HIV status 
of the source patient: 
1. Valid and Invoked Health Care Proxy 
If an individual has a health care proxy, legal documentation should be kept in the medical record 
of the patient to inform health care facilities or clinical practices. A health care proxy assigns 
health decisions for an incapacitated individual to another individual. These decisions can include 
HIV testing and release of the test results.
18
 A health care proxy must be valid (signed by the 
principal and two witnesses who are not the health care agent) and invoked (the attending 
physician determines that the principal is incapacitated and documents it in the medical record). 
Any questions or concerns should be conveyed to the facility’s legal counsel for resolution. 
2. Temporary Guardianship 
In certain circumstances, an incapacitated source patient may have no previous documentation of 
HIV status and no health care proxy. Facility legal staff may choose to pursue a temporary 
guardianship in order to obtain authority for the source patient to be tested for HIV and have the 
test results released to the exposed person. The court determines if an immediate emergency 
situation exists based on the facts of the case, and may choose to shorten or waive the notice 
requirements in order to expedite the appointment of a temporary guardian. The motion should 
specifically request HIV testing and release of results as the nature of the circumstances requiring 
an immediate hearing. Temporary guardianship is valid for 90 days.
19
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